Financhill
Back

Biomarin Pharmaceutical Vs. Target Industry Stock Comparison

Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
22

TGT
Target

Last Price:
125.00
Seasonality Move:
4.08%
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $125.01. The Score for TGT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 518116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.94 - 69.24) Sell
Bollinger Bands (100): (67.93 - 87.19) Sell

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.11 Sell
Relative Strength Index (14 RSI): 28.67 Sell
Chaikin Money Flow: 9125665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (138.23 - 157.41) Sell
Bollinger Bands (100): (141.76 - 157.14) Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.73 Buy
20-day SMA: 65.69 Sell
50-day SMA: 68.56 Sell
200-day SMA: 81.05 Sell
8-day EMA: 63.9 Buy
20-day EMA: 65.57 Sell
50-day EMA: 69.74 Sell
200-day EMA: 79.39 Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.68 Sell
20-day SMA: 147.3 Sell
50-day SMA: 151.17 Sell
200-day SMA: 153.74 Sell
8-day EMA: 137.63 Sell
20-day EMA: 145.05 Sell
50-day EMA: 148.83 Sell
200-day EMA: 149.38 Sell

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.33 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):